Table 3.
E-cadherin |
Snail |
|||||||
---|---|---|---|---|---|---|---|---|
Weighted Averagea |
Worst Coreb |
Weighted Averagea |
Worst Coreb |
|||||
Low | High | Low | High | Low | High | Low | High | |
Stage | ||||||||
Local | 6 | 93 | 3 | 96 | 29 | 69 | 54 | 44 |
Regional | 5 | 61 | 3 | 63 | 14 | 51 | 45 | 20 |
Distant | 0 | 23 | 0 | 23 | 1 | 21 | 13 | 9 |
Mortality risk | ||||||||
Died within 5 years (x) | 7 | 55 | 3 | 59 | 17 | 44 | 43 | 18 |
Total at risk (y) | 11 | 177 | 6 | 182 | 44 | 141 | 112 | 73 |
5-Year risk of death post-surgery (%) (x/y) | 64 | 31 | 50 | 32 | 39 | 31 | 38 | 25 |
Of 190 overall subjects in the EMT study, the number with tumor tissue marker data available was 188 for E-cadherin and 185 for Snail Low expression status is expression in tumor tissue below the statistically-optimal cut point and high expression status is expression in tumor tissue at or above the statistically-optimal cut point. The a priori hypotheses were that low E-cadherin subjects would have worse outcomes while high Snail subjects would have worse outcomes. For the value of the statistically-optimal cut point for each marker expression variable, see “Materials and methods” section
Marker expression values assigned as weighted average of cores in tumor tissue (weighted by area analyzed for E-cadherin and number of nuclei for Snail)
Marker expression values assigned as expression in tumor tissue of the core with lowest expression for E-cadherin and highest expression for Snail